Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients

Renal Failure

Volumn 30, Issue 1, 2008, Pages 81-87

  Visnja, Lezaic ^a   Milan, Stosovic ^a   Jelena, Marinkovic ^b   Vanja, Rangelov ^c   Ljubica, Djukanovic ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Dedinje Cardiovascular Institute   (Serbia)

^c General Hospital U ice   (Serbia)

Author keywords

Hemodialysis patient; Kidney transplant patient; Outcome; Virus hepatitis B and C

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY GRAFT; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL;

ADULT; CAUSE OF DEATH; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 38149045023     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701742211     Document Type: Article

References (24)

1. Radovic M, Nesic V. Annual Report on Regular Dialysis and Transplantation in Serbia and Montenegro 2002. Clinical Center of Serbia, Beograd; 2004.
2. Pereira BJG, Natov SN, Bouthot BA, Murthy BVR, Ruthazer R, Schmid CH, Levey AS; and the New England Organ Bank Hepatitis Study Group. Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int. 1998; 53:1374-1381.
3. Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B. Hepatitis C antibody status and outcomes in renal transplant recipients. Transplantation. 2001;72:241-244.
4. Breitenfeldt MK, Rasenack J, Berthold H, et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant. 2002;16:130-136.
5. Sezer S, Ozdemir FN, Akcay A, Arat Z, Boyacioglu S, Haberal M. Renal transplantation offers a better survival in HCV infected ESRD patients. Clin Transplantation. 2004;18:619-623.
6. Hanafusa T, Ichikawa Y, Kishikawa H, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation. 1998;66:471-476.
7. Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology. 1999;29:257-263.
8. Zylberberg H, Nalpas B, Carnot F, et al. Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant. 2002;17:129-133.
9. Batty DS, Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: Associated factors and patient survival. Am J Transplant. 2001;1:179-184.
10. Morales JM, Domingez-Gil B, Sanz-Guajardo D, Fernandez J, Escuin F. The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure. Nephrol Dial Transplantation. 2004;19 (Suppl. 3):iii72-iii76.
11. Lin H-H, Huang J-Y, Yang C-W, et al. Impact of HCV infection on first cadaveric renal transplantation, a single center experience. Clin Transplantation. 2004;18:261-266.
12. Ozdemir FN, Micozkadioglu H, Sezer S, et al. HCV antibody positivity significantly affects renal allograft survival. Transplant Proc. 2003;35:2701-2702.
13. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725-1730.
14. Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14:3270-3277.
15. Vladutiu D, Cosa A, Neamtu A, et al. Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: Yellow spots on a blank map? J Viral Hepat. 2000;7:313-319.
16. Sayiner AA, Zeytinoglu A, Ozkahya M, et al. HCV infection in hemodialysis and CAPD patients. Nephrol Dial Transplant. 1999;14:256-257.
17. Lezaic V, Djukanovic Lj, Blagojevic R, Radivojevic D. Long-term outcome of kidney transplantation in patients with hepatitis B or C positive. Clin Transplantation. 2003;17:75-76.
18. Sumethkul V, Jirakranont B, Jirasiritham S, Pairoj W. Eleven-year experience of kidney transplantation in patients with hepatitis B and C infection. Transplant Proc. 2000;32:1944-1945.
19. Einollahi B, Hajarizadeh B, Bakhtiari S, et al. Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol. 2003;18:836-840.
20. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Transplantation. 1998;32:629-634.
21. Bloom RD, Sayer G, Fa K, Constantinescu S, Abt P, Reddy KR. Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant. 2005;5:139-144.
22. Legendre C, Garrigue V, Le Bihan C, et al. Harmful longterm impact of hepatitis C virus infection in kidney transplant recipients. Transplantation. 1998;65:667-670.
23. Touru H, Yasuji I, Hidefumi K, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation. 1998;66:471-476.
24. Goral S, Helderman H. The hepatitis C and renal transplantation: The controversy continue-editorial. Kidney Int. 1998;53:1419-1420.